Ovid Therapeutics Inc. – Material Contracts

NASDAQ: OVID
Share price (5/29/26): $2.73
Market cap (5/29/26): $510 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Material Contracts Filter

from 10-Q 4 pages Material contract

from 10-K 16 pages Material contract

from 10-K 17 pages Material contract

from 8-K 23 pages Material contract

from 8-K 52 pages Material contract

from 8-K 22 pages Registration Rights Agreement

from 8-K 63 pages Securities Purchase Agreement

from 10-K 3 pages Material contract

from 10-K 3 pages Material contract

from 10-K 11 pages Material contract

from 10-Q 16 pages Material contract

from 8-K 15 pages Amended and Restated Executive Employment Agreement

from 10-Q 11 pages Material contract

from 10-K 53 pages Material contract

from 10-K 3 pages Material contract

from 10-Q Pdf Courtesy Copy

from 10-Q 3 pages Ovid Therapeutics Inc. Non-Employee Director Compensation Policy

from 8-K 56 pages License Agreement Between Astrazeneca Ab and Ovid Therapeutics Inc. Dated as of December 30, 2021

from 10-Q 3 pages Ovid Therapeutics Inc. Non-Employee Director Compensation Policy

from 10-Q 18 pages Amended and Restated Executive Employment Agreement